National Healthcare Safety Network (NHSN) Data Validation Study for the End-Stage Renal Disease (ESRD) Quality Incentive Program (QIP) (CMS-10639)

Forms and Documents

Document	Type	Status	Availability
Form CMS-10639 National Healthcare Safety Network (NHSN) Data Validation Study for the End-Stage Renal Disease (ESRD) Quality Incentive Program (QIP)	Form and Instruction	Modified	Repair queued
CMS-10639 Supporting Statement A NHSN CY 2021 (6-2-2020).docx	Supporting Statement A	Uploaded 2020-07-14	Repair queued
CMS-10639 Supporting Statement B NHSN CY 2021 (6-2-2020).docx	Supporting Statement B	Uploaded 2020-07-14	Available

IC Document Collections

IC ID	Collection	Type	Status	Form
224551	National Healthcare Safety Network (NHSN) Data Validation Study for the End-Stage Renal Disease (ESRD) Quality Incentive Program (QIP)	Form and Instruction	Modified

ICR Details

OMB Control No: 0938-1340	ICR Reference No: 202007-0938-003
Status: Historical Inactive	Previous ICR Reference No: 201912-0938-018
Agency/Subagency: HHS/CMS	Agency Tracking No: CCSQ
Title: National Healthcare Safety Network (NHSN) Data Validation Study for the End-Stage Renal Disease (ESRD) Quality Incentive Program (QIP) (CMS-10639)
Type of Information Collection: Revision of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Comment filed on proposed rule and continue	Conclusion Date: 08/17/2020
	Date Received in OIRA: 07/15/2020
Terms of Clearance: Prior to publication of the final rule, the agency should provide to OMB a summary of all comments received on the proposed information collection and identify any changes made in response to these comments.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	01/31/2023	36 Months From Approved	01/31/2023
Responses	12,000	0	12,000
Time Burden (Hours)	3,000	0	3,000
Cost Burden (Dollars)	0	0	0

---

Abstract: For the PY 2023 study, CMS is proposing to update this policy to reflect that facilities selected to participate in the NHSN validation study can submit a total of 20 records across any 2 quarters, and are not restricted to the first 2 quarters of the calendar year.

---

Authorizing Statute(s): US Code: 42 USC 1395R Name of Law: End State Renal Disease
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
0938-AU08	Proposed rulemaking	85 FR 42132	07/13/2020

---

Federal Register Notices & Comments

Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
National Healthcare Safety Network (NHSN) Data Validation Study for the End-Stage Renal Disease (ESRD) Quality Incentive Program (QIP)	CMS-10639, CMS-10639	Request Letter to Facilities Records ,   Request Letter to Facilities - List

---

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: Yes

Burden Reduction Due to: Miscellaneous Actions

Short Statement: The changes in burden proposed in this PRA are due to a decrease in NHSN data validation study reporting requirements from 40 records per year to 20 records per year. The burden also changes because the formula is now calculated using the median hourly wage rate, as opposed to the mean hourly wage rate. We made this change to be consistent with other CMS quality reporting and payment programs, which use the median wage rate in their estimates. The annual burden associated with the PY 2023 study is 1,500 hours at a cost of $61,500. This is a decrease of 1,500 hours and $65,460 from the currently approved burden estimate.

---

Annual Cost to Federal Government: $188,271

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     Yes

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 07/15/2020

---